6.471
price up icon2.48%   0.1567
after-market After Hours: 6.47 -0.001 -0.02%
loading
Precipio Inc stock is traded at $6.471, with a volume of 606. It is up +2.48% in the last 24 hours and up +11.57% over the past month. Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
See More
Previous Close:
$6.3143
Open:
$6.471
24h Volume:
606
Relative Volume:
0.09
Market Cap:
$9.59M
Revenue:
$15.81M
Net Income/Loss:
$-4.90M
P/E Ratio:
-1.8921
EPS:
-3.42
Net Cash Flow:
$-2.65M
1W Performance:
+0.13%
1M Performance:
+11.57%
6M Performance:
+20.06%
1Y Performance:
+1.35%
1-Day Range:
Value
$6.471
$6.471
1-Week Range:
Value
$6.2801
$6.73
52-Week Range:
Value
$4.31
$7.25

Precipio Inc Stock (PRPO) Company Profile

Name
Name
Precipio Inc
Name
Phone
203 787 7888
Name
Address
12325 EMMET ST, OMAHA, CT
Name
Employee
57
Name
Twitter
@precipiodx
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
PRPO's Discussions on Twitter

Compare PRPO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
PRPO
Precipio Inc
6.471 9.59M 15.81M -4.90M -2.65M -3.42
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
606.74 232.08B 42.37B 6.14B 7.78B 15.95
Diagnostics & Research icon
DHR
Danaher Corp
223.08 160.42B 23.74B 3.89B 4.98B 5.24
Diagnostics & Research icon
A
Agilent Technologies Inc
151.38 42.01B 6.51B 1.29B 1.37B 4.42
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
201.78 36.62B 15.32B 1.41B 1.96B 7.62
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
423.99 34.72B 3.84B 866.24M 792.60M 10.37

Precipio Inc Stock (PRPO) Latest News

pulisher
Jan 23, 2025

Precipio Grants Options to Officers as Part of Long-Term Incentive Equity Program - Defense World

Jan 23, 2025
pulisher
Jan 21, 2025

Precipio announces executive option grants tied to stock performance - MSN

Jan 21, 2025
pulisher
Jan 20, 2025

(PRPO) Proactive Strategies - Stock Traders Daily

Jan 20, 2025
pulisher
Jan 16, 2025

Precipio Adopts Performance-Based Stock Options for 2025 - TipRanks

Jan 16, 2025
pulisher
Jan 16, 2025

Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs - The Manila Times

Jan 16, 2025
pulisher
Jan 16, 2025

Precipio Management Bets Big: Opts for Stock Options That Only Vest at $30 Share Price - StockTitan

Jan 16, 2025
pulisher
Jan 16, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Jan 16, 2025
pulisher
Jan 16, 2025

The Zacks Analyst Blog Highlights Visa, AbbVie, Analog Devices and Precipio - Yahoo Finance

Jan 16, 2025
pulisher
Jan 15, 2025

Top Research Reports for Visa, AbbVie & Analog Devices - Yahoo Finance

Jan 15, 2025
pulisher
Jan 09, 2025

(PRPO) Trading Report - Stock Traders Daily

Jan 09, 2025
pulisher
Dec 30, 2024

(PRPO) Trading Advice - Stock Traders Daily

Dec 30, 2024
pulisher
Dec 20, 2024

Investors Aren't Entirely Convinced By Precipio, Inc.'s (NASDAQ:PRPO) Revenues - Simply Wall St

Dec 20, 2024
pulisher
Dec 19, 2024

Long Term Trading Analysis for (PRPO) - Stock Traders Daily

Dec 19, 2024
pulisher
Dec 16, 2024

Precipio (NASDAQ:PRPO) Stock Quotes, Forecast and News Summary - Benzinga

Dec 16, 2024
pulisher
Dec 09, 2024

(PRPO) Trading Signals - Stock Traders Daily

Dec 09, 2024
pulisher
Nov 28, 2024

PRPO (Precipio) 3-Year Book Growth Rate : -14.20% (As of Sep. 2024) - GuruFocus.com

Nov 28, 2024
pulisher
Nov 28, 2024

How to Take Advantage of moves in (PRPO) - Stock Traders Daily

Nov 28, 2024
pulisher
Nov 28, 2024

PRPO (Precipio) 3-Year EPS without NRI Growth Rate : 28.00% (As of Sep. 2024) - GuruFocus.com

Nov 28, 2024
pulisher
Nov 28, 2024

PRPO (Precipio) 3-Year EBITDA Growth Rate : 32.10% (As of Sep. 2024) - GuruFocus.com

Nov 28, 2024
pulisher
Nov 28, 2024

PRPO (Precipio) 3-Year Revenue Growth Rate : 16.60% (As of Sep. 2024) - GuruFocus.com

Nov 28, 2024
pulisher
Nov 25, 2024

PRPO (Precipio) Future 3-5Y Total Revenue Growth Rate : N/A (As of Nov. 26, 2024) - GuruFocus.com

Nov 25, 2024
pulisher
Nov 25, 2024

PRPO (Precipio) Growth Rank : 3 (As of Nov. 25, 2024) - GuruFocus.com

Nov 25, 2024
pulisher
Nov 25, 2024

Two Smaller Companies Worthy of Your "Attention" - Yahoo Finance

Nov 25, 2024
pulisher
Nov 25, 2024

PRPO (Precipio) 3-Year FCF Growth Rate : 32.40% (As of Sep. 2024) - GuruFocus.com

Nov 25, 2024
pulisher
Nov 23, 2024

PRPO (Precipio) GF Value Rank : 2 (As of Nov. 23, 2024) - GuruFocus.com

Nov 23, 2024
pulisher
Nov 23, 2024

PRPO (Precipio) Debt-to-Equity : 0.11 (As of Sep. 2024) - GuruFocus.com

Nov 23, 2024
pulisher
Nov 20, 2024

Precipio Inc (PRPO) Q3 2024 Earnings Call Highlights: Strong Growth in Diagnostic Services and ... - Yahoo Finance

Nov 20, 2024
pulisher
Nov 20, 2024

Earnings call: Precipio nears breakeven with robust Q3 growth By Investing.com - Investing.com Canada

Nov 20, 2024
pulisher
Nov 19, 2024

Earnings call: Precipio nears breakeven with robust Q3 growth - Investing.com

Nov 19, 2024
pulisher
Nov 18, 2024

Precipio Reports Improved Financials Amid Challenges - TipRanks

Nov 18, 2024
pulisher
Nov 17, 2024

(PRPO) On The My Stocks Page - Stock Traders Daily

Nov 17, 2024
pulisher
Nov 14, 2024

PRPO (Precipio) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

Insider Sale: Director Richard Sandberg Sells Shares of Precipio Inc (PRPO) - GuruFocus.com

Nov 13, 2024
pulisher
Nov 12, 2024

Precipio director Richard Sandberg sells $12,558 in stock - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

Precipio director Richard Sandberg sells $12,558 in stock By Investing.com - Investing.com UK

Nov 12, 2024
pulisher
Nov 09, 2024

Precipio Third Quarter 2024 Earnings: US$0.42 loss per share (vs US$1.04 loss in 3Q 2023) - Yahoo Finance

Nov 09, 2024
pulisher
Nov 09, 2024

Precipio (NASDAQ: PRPO) to Host Q3-2024 Shareholder Update Call - Defense World

Nov 09, 2024
pulisher
Nov 07, 2024

Precipio to Host Q3-2024 Shareholder Update Call - TipRanks

Nov 07, 2024
pulisher
Nov 07, 2024

Precipio Announces Q3-2024 Shareholder Update Call - The Manila Times

Nov 07, 2024
pulisher
Nov 06, 2024

Precipio (PRPO) Sets Q3 2024 Earnings Call: Cancer Diagnostics Update Coming Nov 18 | PRPO Stock News - StockTitan

Nov 06, 2024
pulisher
Oct 27, 2024

Trend Tracker for (PRPO) - Stock Traders Daily

Oct 27, 2024
pulisher
Oct 08, 2024

Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping - The Manila Times

Oct 08, 2024
pulisher
Oct 08, 2024

PRPO Stock Earnings: Precipio Reported Results for Q2 2024 - MSN

Oct 08, 2024
pulisher
Sep 19, 2024

Precipio (NASDAQ:PRPO) Shares Pass Above Two Hundred Day Moving Average of $5.85 - Defense World

Sep 19, 2024
pulisher
Sep 14, 2024

When the Price of (PRPO) Talks, People Listen - Stock Traders Daily

Sep 14, 2024
pulisher
Sep 07, 2024

Precipio Incentivizes Staff with Strategic Stock Option Repricing - TipRanks

Sep 07, 2024
pulisher
Sep 06, 2024

Precipio Announces Employee Stock Option Plan Repricing - ForexTV.com

Sep 06, 2024
pulisher
Sep 06, 2024

Precipio Announces Stock Option Repricing for Employees - Investing.com

Sep 06, 2024
pulisher
Sep 05, 2024

Zacks Initiates Coverage of Precipio With Outperform Recommendation - Yahoo Finance

Sep 05, 2024
pulisher
Aug 30, 2024

Objective long/short (PRPO) Report - Stock Traders Daily

Aug 30, 2024
pulisher
Aug 26, 2024

Head-To-Head Comparison: Prenetics Global (NASDAQ:PRE) vs. Precipio (NASDAQ:PRPO) - Defense World

Aug 26, 2024

Precipio Inc Stock (PRPO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research LH
$251.54
price up icon 2.16%
$133.01
price up icon 0.98%
$176.27
price up icon 4.79%
diagnostics_research WAT
$417.28
price up icon 3.24%
diagnostics_research MTD
$1,364.50
price up icon 2.17%
$423.99
price up icon 1.25%
Cap:     |  Volume (24h):